RxDoctor Payments Data

Deanna Bianchini, PA

Medical · Exton, PANPI 1538645999

Payments from drug & device makers

$7,738in general payments, 2019–2025

Across 359 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$968
  • Johnson & Johnson$455
  • Incyte Corporation$436
  • Sanofi$434
  • AbbVie$420
  • Daiichi Sankyo Inc.$366
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,738 in reported general payments places this provider in the 90th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$46,637
Medicare patients
188
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib33$494,722
CalquenceAcalabrutinib Maleate23$341,280
TasignaNilotinib Hcl13$334,354
JakafiRuxolitinib Phosphate18$301,538
SprycelDasatinib15$201,617
XtandiEnzalutamide13$185,083
TabrectaCapmatinib Hydrochloride12$134,394
OrgovyxRelugolix33$85,531
EliquisApixaban54$45,143
Abiraterone Acetate19$33,142
XareltoRivaroxaban34$23,054
Oxycodone Hcl23$385
Dexamethasone23$368
Hydroxyurea18$326
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine23$305

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Pharmacyclics LLC, An Abbvie CompanyImbruvica$110$494,72233 claims
NovartisTasigna, Tabrecta$968$468,74825 claims
AstraZenecaCalquence$202$341,28023 claims
Incyte CorporationJakafi$436$301,53818 claims
E.r. Squibb & Sons, L.L.C.Sprycel$95$201,61715 claims
Astellas Pharma US IncXtandi$29$185,08313 claims
PfizerEliquis$84$45,14354 claims
Johnson & JohnsonXarelto$455$23,05434 claims
Lilly USA, LLCOlanzapine$263$8913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Exton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →